Stryker Corporation (NYSE:SYK) acquired Arrinex, Inc. on February 25, 2019. JPMorgan Chase & Co. acted as financial advisor to Arrinex. Wilson Sonsini Goodrich & Rosati, P.C acted as legal advisor to Arrinex. Andrew Ment, Allison Schiffman, Kristen Spitaletta, Tracy Blauweiss, Alison Sikes, Pamela Forest, Douglas Poucher, Lynette Zentgraft, Christina Kuhn, Sarah Cowlishaw, Katharina Ewert, Anna Kraus, Stephanie Doebler, Liza Khan, Rebecca Yergin, Sanchi Khare, Esther Scherb, Michael Francese, Jeff Zink, Ansgar Simon, Jon Endean, Heather Haberl, Ned Dix, Don Elliott, Kamila Lis-Coghlan, James O'Connell, Andrea Zulli and Tawkir Chowdhury of Covington & Burling LLP and Osler, Hoskin & Harcourt LLP acted as legal advisors to Stryker Corporation.
Stryker Corporation (NYSE:SYK) completed the acquisition of Arrinex, Inc. on February 25, 2019.
Stryker Corporation is one of the world's leaders in designing, manufacturing, and selling orthopedic equipments. Net sales break down by family of products as follows:
- surgical equipments and neurotechnology products (57.5%): electric motorized surgical instruments, surgical navigation systems, endoscopy equipment, digital imaging systems, neurosurgery equipments, neurovascular devices, etc. The group also offers hospital beds, gurneys, stretchers, and emergency room equipment;
- orthopedic implants (42.5%): joint prostheses, traumatology implants, micro-implants, orthopedic cement, orthobiology products, etc. The group also provides spinal implants.
At the end of 2022, the group had 48 production sites worldwide.
Net sales are distributed geographically as follows: the United States (73.9%), Europe/Middle East/Africa (12.7%), Asia/Pacific (10.2%) and other (3.2%).